Replies to post #431964 on NorthWest Biotherapeutics Inc (NWBO)

[hoffmann6383]

I'd bet shorting will continue past tld/publication. I see it going till meaningful revenue happens. To lessen the shorting we would need an uplisting, regulatory approval and meaningful revenue. Or, simply a buyout.

Unless we get some additional news at TLD/Publication (i.e. regulatory approval), the TLD will be attacked relentlessly by shorts.

We still have a long ways to go.

[VikingInvest]

If you are informed about this company, you would have sold in November and bought back prior to Dec. 31, which is what I did. Yes, I could have gotten screwed by the Sawston news, and I feel super lucky that it came back down after the initial spike, so I could get back in last week. Sometimes you are the bug and sometimes you are the windshield. If people sold for tax loss purposes last week, they have to wait until end of January to buy back in. I highly doubt any of the buying right now are from people who sold to get a tax loss. The buying is likely Roth contributions or some smaller institutions who had to get out before end of last quarter, who are now getting back in. I think we will see more of those kind of sales as time goes by and we get closer to TLD/Publication.